Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Food
GlacBiotech-Approval

More Like This

PR Newswire associated0

BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025

21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology

PR Newswire associated0

Angel Group's First Industrialized Strain of Probiotics Anchors Strategic Transformation Towards Biotechnology

Bifidobacterium infantis M-63 is a unique probiotic strain of human-residential bifidobacteria (HRB) – bifidobacteria that naturally reside in the human gut – and is renowned for its ability to utilize human milk oligosaccharides (HMO) found in breast milk, significantly improving the intestinal environment of healthy full-term infants. (Graphic: Business Wire)

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods

PR Newswire associated0

Angel Yeast Expands into Probiotics R&D and Production, Advances Biotech Transformation

Clinigen Announces World-First Pharmaceutical Approval for Prolacta Bioscience's PreemieFort® Enteral Solution, Human Milk-Based Product in Japan

PR Newswire associated0

PROBIOS TO ACQUIRE 100 % OF BIOTOBIO

PR Newswire associated0

Biotic innovation tackles iron deficiency in women - now recognized across three continents